V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009924 | 330010448 | 1.68 | 102.8 | null | null | 2016-10-22 | OST Euramos 1 Closed Trial - M | N | N | 330008309 | METHOTREXATE HIGH DOSE |
| 330009925 | 330004035 | 1.68 | 61.3 | null | 2015-06-08 | 2017-01-23 | OST Euramos 1 Closed Trial - M | N | N | 330008317 | METHOTREXATE HIGH DOSE |
| 330009926 | 330004038 | 1.93 | 80.5 | Curative (C) | 2018-06-16 | 2018-06-16 | Rituximab | N | N | 330008356 | RITUXIMAB |
| 330009928 | 330004041 | 1.82 | 24.9 | Neo-adjuvant (N) | 2014-03-28 | 2014-04-04 | MAP | N | N | 330008365 | MAP |
| 330009929 | 330004041 | 1.77 | 101.3 | Curative (C) | 2017-07-12 | 2017-08-10 | OST Euramos 1 Closed Trial - M | 02 | N | 330008365 | METHOTREXATE HIGH DOSE |
| 330009930 | 330004045 | 1.85 | 62.3 | null | 2016-05-01 | 2016-05-02 | MAP | 2 | N | 330008372 | MAP |
| 330009932 | 330004049 | 0 | null | Curative (C) | 2016-12-18 | 2016-12-18 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008382 | MAP |
| 330009933 | 330004052 | 1.79 | 114 | Curative (C) | 2015-09-29 | 2015-09-29 | Rituximab | N | Y | 330008383 | RITUXIMAB |
| 330009934 | 330004054 | 1.59 | 63 | Palliative (P) | 2018-01-12 | 2018-01-30 | OST Euramos 1 Closed Trial - M | N | N | 330008390 | METHOTREXATE HIGH DOSE |
| 330009935 | 330004056 | null | 80.5 | Palliative (P) | 2015-03-24 | 2015-07-22 | Cisplatin +Fluorouracil (3 wk) | null | null | 330008395 | CISPLATIN + FLUOROURACIL |
| 330009936 | 330004058 | 1.78 | null | Palliative (P) | 2016-11-25 | 2016-11-29 | Cisplatin +Fluorouracil (3 wk) | null | null | 330008397 | CISPLATIN + FLUOROURACIL |
| 330009937 | 330004060 | 1.8 | 95.6 | Palliative (P) | 2014-01-10 | 2014-01-15 | Carboplatin AUC 2 - 5 | 02 | N | 330008427 | CARBOPLATIN |
| 330009938 | 330008213 | 0 | null | Curative (C) | 2018-04-17 | 2018-04-17 | CETUXIMAB | N | N | 330008443 | CETUXIMAB |
| 330009939 | 330004063 | null | 47.4 | Palliative (P) | 2014-12-25 | 2015-01-24 | Etoposide + Ifosfamide (5 days) | 2 | N | 330008460 | ETOPOSIDE + IFOSFAMIDE |
| 330009940 | 330004066 | 1.67 | 75 | Curative (C) | 2018-01-28 | 2018-02-23 | PAM x 2 pre-surgery (cycles 1&2) | N | Y | 330008495 | MAP |
| 330009943 | 330004069 | 1.62 | 58 | Curative (C) | 2013-08-13 | 2014-02-05 | OST Euramos 1 Closed Trial - M | null | null | 330008562 | METHOTREXATE HIGH DOSE |
| 330009944 | 330004071 | 1.6 | 61.3 | Curative (C) | 2017-07-18 | 2017-08-02 | Etoposide + Ifosfamide (3 days) | 2 | N | 330008566 | ETOPOSIDE + IFOSFAMIDE |
| 330009945 | 330004074 | 1.81 | 47.9 | Neo-adjuvant (N) | 2016-02-20 | 2016-03-22 | CISPLATIN + FLUOROURACIL | N | N | 330008567 | CISPLATIN + FLUOROURACIL |
| 330009946 | 330004075 | null | 62.2 | Palliative (P) | null | 2017-07-25 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008567 | DOCETAXEL + GEMCITABINE |
| 330009947 | 330004077 | 1.55 | null | Palliative (P) | 2015-06-14 | 2015-06-15 | Carboplatin AUC 2 - 5 | null | null | 330008586 | CARBOPLATIN |
| 330009948 | 330004078 | 1.67 | null | Curative (C) | 2017-10-17 | 2017-10-17 | Rituximab | 02 | N | 330008592 | RITUXIMAB |
| 330009949 | 330004080 | 1.69 | 60.3 | Neo-adjuvant (N) | 2017-12-11 | 2017-12-11 | Etoposide + Ifosfamide (3 days) | null | null | 330008603 | ETOPOSIDE + IFOSFAMIDE |
| 330009950 | 330004082 | 1.67 | 63.9 | Palliative (P) | 2015-07-09 | 2015-07-23 | CISPLATIN + FLUOROURACIL | null | null | 330008614 | CISPLATIN + FLUOROURACIL |
| 330009951 | 330013027 | null | 121.6 | Curative (C) | 2018-01-11 | 2018-02-16 | CISPLATIN + FLUOROURACIL | 02 | null | 330008637 | CISPLATIN + FLUOROURACIL |
| 330009952 | 330013243 | 1.83 | 76.25 | null | 2013-05-30 | 2013-06-02 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008639 | DOCETAXEL + GEMCITABINE |
| 330009953 | 330008226 | 1.77 | 91 | Disease modification (D) | 2016-06-21 | 2016-09-24 | Rituximab (Maintenance) | N | N | 330008666 | RITUXIMAB |
| 330009954 | 330008226 | 1.72 | 19.2 | Curative (C) | 2017-11-26 | 2018-05-03 | Rituximab | N | N | 330008666 | RITUXIMAB |
| 330009955 | 330004085 | 0 | 21.7 | Palliative (P) | 2015-12-18 | 2015-12-23 | CISPLATIN + FLUOROURACIL | N | N | 330008687 | CISPLATIN + FLUOROURACIL |
| 330009956 | 330004087 | 1.67 | null | Palliative (P) | 2014-05-07 | 2014-05-28 | MAP | N | N | 330008704 | MAP |
| 330009957 | 330004088 | 1.77 | 88.6 | Palliative (P) | 2018-04-21 | 2018-04-23 | CARBOPLATIN | N | N | 330008707 | CARBOPLATIN |
| 330009958 | 330004089 | 1.8 | 65.8 | Palliative (P) | 2015-11-27 | 2016-02-15 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008733 | ETOPOSIDE + IFOSFAMIDE |
| 330009959 | 330004090 | 1.7 | 47.2 | Palliative (P) | 2017-02-20 | 2017-03-18 | Rituximab | 02 | N | 330008744 | RITUXIMAB |
| 330009960 | 330004090 | 1.59 | 72 | Curative (C) | 2016-08-02 | 2016-08-13 | Carboplatin AUC 6 - 10 | N | null | 330008744 | CARBOPLATIN |
| 330009961 | 330004092 | 1.85 | 68 | Palliative (P) | 2013-03-15 | 2013-07-31 | CETUXIMAB | N | N | 330008764 | CETUXIMAB |
| 330009962 | 330004092 | 1.67 | 87.8 | Curative (C) | 2014-06-14 | 2014-06-21 | Etoposide + Ifosfamide (5 days) | N | N | 330008764 | ETOPOSIDE + IFOSFAMIDE |
| 330009963 | 330013029 | 1.67 | 51.3 | null | null | 2018-10-08 | OST Euramos 1 Closed Trial - M | N | N | 330008805 | METHOTREXATE HIGH DOSE |
| 330009964 | 330004094 | 1.63 | 58 | Palliative (P) | 2017-12-08 | 2018-01-18 | MAP | N | N | 330008810 | MAP |
| 330009965 | 330004096 | 1.71 | 66 | Curative (C) | 2015-06-28 | 2015-06-30 | CARBOPLATIN | 2 | N | 330008813 | CARBOPLATIN |
| 330009966 | 330004098 | null | 56.8 | Palliative (P) | 2015-12-24 | 2017-08-05 | CISPLATIN + FLUOROURACIL | N | N | 330008821 | CISPLATIN + FLUOROURACIL |
| 330009968 | 330008236 | 1.6 | 65.3 | null | 2014-08-23 | 2015-04-05 | Rituximab (Maintenance) | N | N | 330008835 | RITUXIMAB |
| 330009969 | 330004102 | 1.7 | 67.3 | Palliative (P) | 2015-07-28 | 2016-01-25 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008865 | MAP |
| 330009970 | 330004103 | 1.9 | 78.8 | Palliative (P) | 2014-11-03 | 2014-11-04 | PAM x 2 post-surgery (cycles 3&4) | 2 | N | 330008887 | MAP |
| 330009971 | 330004103 | null | 24.9 | Palliative (P) | 2015-01-13 | 2015-01-18 | Carboplatin AUC 6 - 10 | 02 | Y | 330008887 | CARBOPLATIN |
| 330009972 | 330004105 | 1.82 | null | Curative (C) | 2016-10-21 | 2016-11-02 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008905 | MAP |
| 330009973 | 330004109 | 1.79 | 69 | Palliative (P) | 2018-04-17 | 2018-04-17 | Docetaxel + Gemcitabine (prior RT) | Y | Y | 330008907 | DOCETAXEL + GEMCITABINE |
| 330009975 | 330004112 | 1.88 | 58.1 | Palliative (P) | 2016-06-23 | 2016-07-11 | CARBOPLATIN | N | N | 330008927 | CARBOPLATIN |
| 330009977 | 330008246 | 1.67 | null | Adjuvant (A) | 2015-11-10 | 2015-11-23 | MAP | N | N | 330008951 | MAP |
| 330009978 | 330004120 | 1.6 | 54.8 | null | 2017-11-04 | 2017-12-12 | MAP | N | N | 330008953 | MAP |
| 330009979 | 330004122 | 1.6 | 68 | Curative (C) | 2017-10-28 | 2017-12-01 | Rituximab | null | null | 330008977 | RITUXIMAB |
| 330009980 | 330004125 | 1.73 | 30.3 | Adjuvant (A) | 2016-12-19 | 2017-01-07 | OST Euramos 1 Closed Trial - M | 02 | N | 330008977 | METHOTREXATE HIGH DOSE |